Catalysts
TSHA Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
TSHATaysha Gene Therapies, Inc.
Healthcare / Biotechnology
Low Priority
In Line With Peers
Latest quote
- Momentum32
- Value—
- Quality37
- Risk resilience37
- Sentiment—
Stock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 32/100 and sentiment — before the next covered event.
Updated Nov 15, 2026 · Sentiment 23.72%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | — | -$0.13 | -$0.10 | +22.2% | $755.56K | — |
| Aug 11, 2026 | — | -$0.11 | -$0.13 | -14.8% | $680K | — |
| May 6, 2026 | — | -$0.10 | -$0.12 | -20.0% | $755.56K | — |
| Mar 19, 2026 | — | -$0.11 | -$0.08 | +27.3% | $2.24M | $5.48M |
| Nov 4, 2025 | — | -$0.09 | -$0.09 | +0.0% | $1.89M | — |
| Aug 12, 2025 | — | -$0.07 | -$0.09 | -28.6% | $1.73M | $1.99M |
| May 15, 2025 | — | -$0.08 | -$0.08 | +0.0% | $1.08M | $2.3M |
| Feb 26, 2025 | — | -$0.08 | -$0.07 | +12.5% | $2.05M | $2.02M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on November 2, 2026, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, restricted stock units (RSUs) representing 25,000 shares of the Company’s common stock in connection with their employment. The RSUs were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 1, 2026, the Compensation Committee of Taysha's Board of Directors granted five new employees restricted stock units (RSUs) representing 314,000 shares of the Company’s common stock and an option to purchase 92,400 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
Related Links
TSHA Catalysts FAQ
What are the next catalysts for TSHA stock?
TSHA's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move TSHA stock?
Upcoming events that could move TSHA include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could TSHA's next earnings report affect the stock?
TSHA's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive TSHA stock higher?
TSHA could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt TSHA stock?
TSHA could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.